Trial Details

COMPLETED
Basic Information
Clinical ID c1634
Identifier NCT00618202
Trial Title A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Balsalazide Disodium 750 mg Capsules Under Fasting Conditions
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: Balsalazide
Participant Information
Sponsor Roxane Laboratories
City Houston
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type INTERVENTIONAL
Phase -
Time Information
Start Date 2025-05-05
Primary Completion Date 2025-06-05
Completion Date 2025-06-05